Howland Capital Management LLC Bristol Myers Squibb CO Transaction History

Howland Capital Management LLC

  • $2.07 Billion
  • Q2 2024

A detailed history of Howland Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Howland Capital Management LLC holds 21,918 shares of BMY stock, worth $1.18 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
21,918
Previous 24,929 12.08%
Holding current value
$1.18 Million
Previous $1.35 Million 32.64%
% of portfolio
0.04%
Previous 0.07%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
SELL
$40.25 - $52.99 $121,192 - $159,552
-3,011 Reduced 12.08%
21,918 $910,000
Q1 2024

May 03, 2024
BUY
$47.98 - $54.4 $17,464 - $19,801
364 Added 1.48%
24,929 $1.35 Million
Q4 2023

Jan 23, 2024
SELL
$48.48 - $57.85 $36,311 - $43,329
-749 Reduced 2.96%
24,565 $1.26 Million
Q3 2023

Oct 17, 2023
SELL
$57.89 - $64.73 $10,883 - $12,169
-188 Reduced 0.74%
25,314 $1.47 Million
Q2 2023

Jul 28, 2023
SELL
$63.71 - $70.74 $3,185 - $3,536
-50 Reduced 0.2%
25,502 $1.63 Million
Q1 2023

May 05, 2023
SELL
$65.71 - $74.53 $33,512 - $38,010
-510 Reduced 1.96%
25,552 $1.77 Million
Q4 2022

Jan 30, 2023
BUY
$68.48 - $81.09 $59,920 - $70,953
875 Added 3.47%
26,062 $1.87 Million
Q3 2022

Oct 17, 2022
BUY
$0.13 - $76.84 $499 - $295,219
3,842 Added 18.0%
25,187 $1.79 Million
Q2 2022

Jul 22, 2022
BUY
$72.62 - $79.98 $705,140 - $776,605
9,710 Added 83.46%
21,345 $1.66 Million
Q1 2022

Apr 27, 2022
BUY
$61.48 - $73.72 $20,288 - $24,327
330 Added 2.92%
11,635 $850,000
Q4 2021

Jan 26, 2022
SELL
$53.63 - $62.52 $45,960 - $53,579
-857 Reduced 7.05%
11,305 $705,000
Q3 2021

Oct 25, 2021
SELL
$59.17 - $69.31 $23,668 - $27,724
-400 Reduced 3.18%
12,162 $720,000
Q2 2021

Jul 28, 2021
SELL
$61.91 - $67.42 $235,567 - $256,533
-3,805 Reduced 23.25%
12,562 $839,000
Q1 2021

Apr 28, 2021
SELL
$59.34 - $66.74 $55,186 - $62,068
-930 Reduced 5.38%
16,367 $1.03 Million
Q4 2020

Jan 26, 2021
SELL
$57.74 - $65.43 $56,642 - $64,186
-981 Reduced 5.37%
17,297 $1.07 Million
Q3 2020

Oct 26, 2020
SELL
$57.43 - $63.64 $28,427 - $31,501
-495 Reduced 2.64%
18,278 $1.1 Million
Q2 2020

Jul 15, 2020
SELL
$54.82 - $64.09 $97,579 - $114,080
-1,780 Reduced 8.66%
18,773 $1.1 Million
Q1 2020

Apr 13, 2020
SELL
$46.4 - $67.43 $5.92 Million - $8.6 Million
-127,566 Reduced 86.12%
20,553 $1.15 Million
Q4 2019

Jan 23, 2020
BUY
$49.21 - $64.19 $5.76 Million - $7.52 Million
117,144 Added 378.19%
148,119 $9.51 Million
Q3 2019

Oct 22, 2019
BUY
$42.77 - $50.71 $209,573 - $248,479
4,900 Added 18.79%
30,975 $1.57 Million
Q2 2019

Jul 17, 2019
SELL
$44.62 - $49.34 $249,336 - $275,711
-5,588 Reduced 17.65%
26,075 $1.18 Million
Q1 2019

Apr 22, 2019
SELL
$45.12 - $53.8 $54,369 - $64,829
-1,205 Reduced 3.67%
31,663 $1.51 Million
Q4 2018

Jan 23, 2019
SELL
$48.76 - $63.23 $916,785 - $1.19 Million
-18,802 Reduced 36.39%
32,868 $1.71 Million
Q3 2018

Oct 25, 2018
BUY
$55.19 - $62.25 $37,418 - $42,205
678 Added 1.33%
51,670 $3.21 Million
Q2 2018

Jul 23, 2018
BUY
$50.53 - $62.98 $32,339 - $40,307
640 Added 1.27%
50,992 $2.82 Million
Q1 2018

May 02, 2018
BUY
$59.92 - $68.98 $465,278 - $535,629
7,765 Added 18.23%
50,352 $3.19 Million
Q4 2017

Feb 01, 2018
SELL
$59.94 - $65.35 $6,893 - $7,515
-115 Reduced 0.27%
42,587 $2.61 Million
Q3 2017

Oct 30, 2017
BUY
$55.23 - $63.74 $2.36 Million - $2.72 Million
42,702
42,702 $2.72 Million

Others Institutions Holding BMY

# of Institutions
2,407
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Howland Capital Management LLC Portfolio

Follow Howland Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howland Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Howland Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email